Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer
Authors:
- H J BursteinHBH J Burstein
- Panelists of the St. Gallen International Breast Cancer Consensus 2025P2Panelists of the St. Gallen International Breast Cancer Consensus 2025
Top Cited Papers
Open Access
- 9 October 2025
- journal article
- practice guideline
- Published by Elsevier in Annals of Oncology
- Vol. 36 (12) , 1433-1446
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced NeuropathyJAMA Oncology, 2025
- Adjuvant Atezolizumab for Early Triple-Negative Breast CancerJAMA, 2025
- Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In SituJAMA, 2025
- Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based ReconstructionJAMA Oncology, 2024
- Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant ChemotherapyJAMA Oncology, 2024
- Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph NodesJAMA Oncology, 2023
- Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral BreastJAMA Oncology, 2020
- Population-based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node-positive invasive lobular carcinoma of the breastBritish Journal of Surgery, 2018
- Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2017
- Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast CancerJAMA, 2013